Matt Murphy
Manager of Investor Relations
Replay available
Cara Therapeutics, Inc. (NASDAQ: CARA) Q3 2022 earnings conference call, held 2022-11-07. Replay captured from the company's public earnings webcast.

Manager of Investor Relations
Chief Executive Officer
Chief Financial Officer
Analyst, Canaccord Genuity
Analyst, Needham & Company
Analyst, JP Morgan
Analyst, C4
Analyst, Piper Sandler
Watch the replay and follow the connected company analysis, news, and investor updates for Tvardi Therapeutics, Inc..
WEBVTT 00:00:00.029 -- 00:00:04.293 Good afternoon. My name is Shannon, and I will be your conference facilitator. 00:00:04.293 -- 00:00:08.636 I would like to welcome everyone to the Carer Therapeutics third quarter 2022 financial 00:00:08.636 -- 00:00:12.840 results and update conference call. All lines have been placed on mute to avoid any background 00:00:12.840 -- 00:00:17.084 noise. After the speaker's remarks, there will be a question and answer session. 00:00:17.084 -- 00:00:20.236 If you would like to ask a question during this time, simply press star and the number 00:00:20.236 -- 00:00:25.271 11 on your telephone keypad. Please be advised that this call is being 00:00:25.271 -- 00:00:30.031 recorded. I'll now like to introduce Matt Murphy, CARA's Manager of Investor Relations. 00:00:30.031 -- 00:00:33.112 Mr. Murphy, you may begin your call. 00:00:33.474 -- 00:00:38.478 Thank you, operator, and good afternoon. Just after market closed today, CARA issued 00:00:38.478 -- 00:00:44.163 a news release announcing the company's results for the third quarter of 2022. 00:00:44.163 -- 00:00:48.686 Copies of this news release and SEC filings can be found in the investor section of our 00:00:48.686 -- 00:00:52.028 website at www.caratherapeutics.com. 00:00:53.769 -- 00:00:57.151 Before we begin, I would like to remind you that during the course of this conference 00:00:57.151 -- 00:01:02.095 call, we will be making certain forward-looking statements about CARA and our programs 00:01:02.095 -- 00:01:05.437 based on management's current plans and expectations. 00:01:05.437 -- 00:01:09.350 These statements are being made under the Private Securities Litigation Reform Act of 00:01:09.350 -- 00:01:11.001 1995, 00:01:11.001 -- 00:01:14.504 and they are subject to various ri...